熱門資訊> 正文
AngioDynamics SEARCH 2 2026年盈利预览
2026-01-06 00:25
- AngioDynamics (ANGO) is scheduled to announce FQ2 earnings results on Tuesday, January 6th, before market open.
- The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is $76.43M.
- Over the last 2 years, ANGO has beaten EPS estimates 63% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 1 upward revision and 1 downward.
More on AngioDynamics
- AngioDynamics: Growth Remains Under The Radar
- AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript
- Seeking Alpha’s Quant Rating on AngioDynamics
- Historical earnings data for AngioDynamics
- Financial information for AngioDynamics
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。